![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Pharmacia & Upjohn Company Kalamazoo Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Triamcinolone 3, (21-(acetyloxy)pregna-1,4,9(11)-16-tetraene-3,20-dione), supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2001-230 - Rev 00
This TSE Type CEP, issued on April 09, 2002, remains in force until April 24, 2006, ensuring its reliability within the pharmaceutical industry.